GTHP (Guided Therapeutics) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GTHP Guided Therapeutics Inc GTHP
25 GF Score
Price $0.22
GF Value $1.08
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics Unearned Premiums?

Unearned Premiums only applies to insurance companies.

GTHP
25GF Score
Guided Therapeutics Inc GTHP
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guided Therapeutics (GTHP) Overvalued in 2026?

Based on GuruFocus' analysis, Guided Therapeutics stock appears to be undervalued. The current stock price of $0.22 is trading 79.9% below its estimated GF Value™ of $1.08. GuruFocus considers Guided Therapeutics to be Possible Value Trap.

Key valuation signals for GTHP:

  • Unearned Premiums:
  • GF Value™: $1.08 vs. price of $0.22 (79.9% below fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the GTHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
25GF Score

Get the complete analysis for GTHP

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$1.08
GF Value